Name: Therapies Delivered by Automatic Implantable Defibrillators (en Inglés)
Price: 93510.00 CLP
Availability: InStock
Author: Kamoun, Sofien ; Ben Mrad, Imtinene ; Ben Dou Dou, Marwa
ISBN: 9786204080697

portada Therapies Delivered by Automatic Implantable Defibrillators (en Inglés)

Formato

Libro Físico

Autor

Sofien Kamoun

Imtinene Ben Mrad

Marwa Ben Dou Dou

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.6 cm

Peso

0.15 kg.

ISBN13

9786204080697

Categorías

Cuestiones generales de la medicina

Therapies Delivered by Automatic Implantable Defibrillators (en Inglés)

Sofien Kamoun (Autor) · Imtinene Ben Mrad (Autor) · Marwa Ben Dou Dou (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo

$ 93.510

$ 129.870

Ahorras: $ 36.360

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 09 de Agosto y el Miércoles 21 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Therapies Delivered by Automatic Implantable Defibrillators (en Inglés)"

Appropriate effective therapy is the essential goal of the implantable automatic defibrillator. The occurrence of inappropriate therapy is a potentially serious event. Methods: We conducted a study that included 80 patients implanted with ICDs in the cardiology department of Habib Thameur Hospital in Tunis between January 2010 and June 2019. Results: The median age of the patients was 58 years (52.25-65.75) with a sex ratio of 12.1H/F. During a median follow-up of 48 months, 695 therapies were recorded: 62% anti-tachycardia pacing (ATP) and 38% shocks with a predominance of appropriate therapies (87.8%).The incidence of therapies was 4.72 therapies/patient-year at 1 year, 3.28 therapies/patient-year at 3 years and 0.78 therapies/patient-year at 5 years. In multivariate analysis, the independent predictors of death were inappropriate therapy (RR = 1.102 with a 95% CI of (1.026-1.184), p=0.008), ischemic heart disease (RR = 2.965 with a 95% CI of (0.931-9.444), p=0.066), and LVEF less than 29% (RR = 2.340 with a 95% CI of (0.942-5.809), p=0.067